WO2026103350 - ANTI-TUMOR AND/OR ANTI-FERROPTOSIS SMALL MOLECULE COMPOSITION AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2026/103350
Publication Date
21.05.2026
International Application No.
PCT/CN2025/123418
International Filing Date
23.09.2025
Title **
[English]
ANTI-TUMOR AND/OR ANTI-FERROPTOSIS SMALL MOLECULE COMPOSITION AND USE THEREOF
[French]
COMPOSITION ANTITUMORALE ET/OU ANTI-FERROPTOSE À PETITES MOLÉCULES ET SON UTILISATION
[Chinese]
抗肿瘤和/或抗铁死亡的小分子组合物及其应用
Applicants **
BEIJING HEBABIZ BIOTECHNOLOGY CO., INC
Inventors
ZHOU, James
XIE, Baibo
Priority Data
202411608180.1
12.11.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1570 | |
| EPO | Filing, Examination, Granting | 11616 | |
| Japan | Filing, Examination, Granting | 2017 | |
| South Korea | Filing, Examination, Granting | 1780 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
21,723
Contact Us
Abstract[English]
A small molecule composition, comprising licochalcone A, licochalcone C, licochalcone D, licochalcone E, echinatin, isoliquiritigenin, formononetin, liquiritigenin, licoflavone C, glabrol, licoisoflavone A and licoisoflavone B, and the use thereof in preparing anticancer or antitumor drugs, anti-ferroptosis drugs, or drugs for sensitization of anticancer or antitumor drugs. The small molecule composition can also be used in combination with other antitumor drugs.[French]
Sont divulgués une composition à petites molécules, comprenant du licochalcone A, du licochalcone C, du licochalcone D, du licochalcone E, de l'échinatine, de l'isoliquiritigénine, de la formononetine, de la liquiritigénine, de la licoflavone C, du glabrol, de la licoisoflavone A et de la licoisoflavone B, ainsi que leur utilisation dans la préparation de médicaments anticancéreux ou antitumoraux, de médicaments anti-ferroptose ou de médicaments pour la sensibilisation de médicaments anticancéreux ou antitumoraux. La composition à petites molécules peut également être utilisée en combinaison avec d'autres médicaments antitumoraux.[Chinese]
小分子组合物，包含甘草查耳酮A、甘草查耳酮C、甘草查耳酮D、甘草查耳酮E、刺甘草查耳酮、异甘草素、芒柄花素、甘草素、甘草黄酮C、光甘草酚、甘草异黄酮A和甘草异黄酮B，其可用于制备抗癌或肿瘤、抗细胞铁死亡，或者用于抗癌或肿瘤药物增敏的药物中的应用，所述小分子组合物还可以与其他抗肿瘤药物组合。